Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 3 |
NetGPI | no | yes: 0, no: 3 |
Related structures:
AlphaFold database: A4HE98
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0003998 | acylphosphatase activity | 6 | 4 |
GO:0016462 | pyrophosphatase activity | 5 | 4 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 4 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.478 |
CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.273 |
CLV_NRD_NRD_1 | 191 | 193 | PF00675 | 0.484 |
DOC_ANK_TNKS_1 | 129 | 136 | PF00023 | 0.273 |
DOC_CYCLIN_RxL_1 | 43 | 54 | PF00134 | 0.464 |
DOC_CYCLIN_yCln2_LP_2 | 38 | 44 | PF00134 | 0.474 |
DOC_PP4_FxxP_1 | 36 | 39 | PF00568 | 0.489 |
DOC_WW_Pin1_4 | 156 | 161 | PF00397 | 0.277 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.527 |
DOC_WW_Pin1_4 | 37 | 42 | PF00397 | 0.487 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.506 |
LIG_14-3-3_CanoR_1 | 24 | 29 | PF00244 | 0.507 |
LIG_14-3-3_CanoR_1 | 61 | 65 | PF00244 | 0.497 |
LIG_14-3-3_CanoR_1 | 94 | 100 | PF00244 | 0.496 |
LIG_Actin_WH2_2 | 103 | 121 | PF00022 | 0.273 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.273 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.666 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.273 |
LIG_FHA_2 | 163 | 169 | PF00498 | 0.273 |
LIG_LIR_Nem_3 | 98 | 102 | PF02991 | 0.273 |
LIG_SH2_CRK | 115 | 119 | PF00017 | 0.284 |
LIG_SH2_CRK | 3 | 7 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.352 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.462 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.482 |
LIG_SUMO_SIM_par_1 | 47 | 54 | PF11976 | 0.469 |
MOD_CDK_SPxxK_3 | 63 | 70 | PF00069 | 0.477 |
MOD_CK1_1 | 179 | 185 | PF00069 | 0.736 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.489 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.461 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.439 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.578 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.273 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.427 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.482 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.421 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.573 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.284 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.471 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.419 |
MOD_NEK2_2 | 12 | 17 | PF00069 | 0.468 |
MOD_PIKK_1 | 143 | 149 | PF00454 | 0.236 |
MOD_PIKK_1 | 170 | 176 | PF00454 | 0.446 |
MOD_PKA_1 | 113 | 119 | PF00069 | 0.273 |
MOD_PKA_1 | 192 | 198 | PF00069 | 0.436 |
MOD_PKA_2 | 60 | 66 | PF00069 | 0.509 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.254 |
MOD_Plk_1 | 90 | 96 | PF00069 | 0.423 |
MOD_ProDKin_1 | 156 | 162 | PF00069 | 0.277 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.526 |
MOD_ProDKin_1 | 37 | 43 | PF00069 | 0.488 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.505 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.284 |
TRG_ENDOCYTIC_2 | 3 | 6 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.273 |
TRG_Pf-PMV_PEXEL_1 | 130 | 134 | PF00026 | 0.273 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IDK0 | Leishmania donovani | 77% | 100% |
Q4Q9P3 | Leishmania major | 71% | 100% |